CME 
JOBS 
OUTBREAKS 
PEER-TO-PEER 
QUIZZES & QUESTIONS 
MEDTECH Few classes of therapeutics have been specifically developed to combat migraine, despite its global impact on disability. However, after 30 years of translational research, calcitonin gene-related peptide (CGRP) inhibitors have emerged as a promising new tool in the prevention of migraine.
Peer-influenced content. Sources you trust. No registration required. This is HCN.
